Compounds > 1-(2-chloroethyl)-3-(2,6-dioxo-3-piperidinyl)-1-nitrosourea
Page last updated: 2024-08-22

1-(2-chloroethyl)-3-(2,6-dioxo-3-piperidinyl)-1-nitrosourea and Ependymoma

1-(2-chloroethyl)-3-(2,6-dioxo-3-piperidinyl)-1-nitrosourea has been researched along with Ependymoma in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Badnitsky, S; Burger, P; Krischer, J; Ragab, AH; Van Eys, J1

Other Studies

1 other study(ies) available for 1-(2-chloroethyl)-3-(2,6-dioxo-3-piperidinyl)-1-nitrosourea and Ependymoma

ArticleYear
PCNU in the treatment of recurrent medulloblastoma and ependymoma--a POG Study.
    Journal of neuro-oncology, 1986, Volume: 3, Issue:4

    Topics: Adolescent; Brain Neoplasms; Child; Child, Preschool; Drug Evaluation; Ependymoma; Humans; Medulloblastoma; Neoplasm Recurrence, Local; Nitrosourea Compounds; Thrombocytopenia; Tomography, X-Ray Computed

1986